MiR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis

Gene

Volumn 544, Issue 2, 2014, Pages 128-133

  Honardoost, Mohammad Amin ^a   Kiani Esfahani, Abbas ^b   Ghaedi, Kamran ^a,b,c   Etemadifar, Masoud ^d,e   Salehi, Mansoor ^d  

^a UNIVERSITY OF ISFAHAN   (Iran)

^b ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Multiple Sclerosis and Neuroimmunology Research Center   (Iran)

Author keywords

MicroRNA; MiR 26a; MiR 326; Relapsing remitting multiple sclerosis; Th 17 cells

Indexed keywords

MICRORNA; MICRORNA 26A; MICRORNA 326; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EVALUATION STUDY; GENE EXPRESSION; HUMAN; MULTIPLE SCLEROSIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RELAPSE; REMISSION; SENSITIVITY AND SPECIFICITY; TH17 CELL; UPREGULATION;

MICRORNA; MIR-26A; MIR-326; RELAPSING-REMITTING MULTIPLE SCLEROSIS; TH-17 CELLS;

CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; MALE; MICRORNAS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RECURRENCE; STAT1 TRANSCRIPTION FACTOR; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84900489623     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.04.069     Document Type: Article

References (32)

1. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., Sallusto F. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nature Immunology 2007, 8:942-949.
2. Annunziato F., Romagnani S. Do studies in humans better depict Th17 cells?. Blood 2009, 114:2213-2219.
3. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
4. Bendszus M., Storch-Hagenlocher B. Multiple Sclerosis and Other Demyelinating Diseases, Inflammatory Diseases of the Brain 2013, 3-18. Springer.
5. Brucklacher-Waldert V., Stuerner K., Kolster M., Wolthausen J., Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009, 132:3329-3341.
6. Calabresi P.A. Diagnosis and management of multiple sclerosis. American Family Physician 2004, 70:1935-1944.
7. Da Wei Huang B.T.S., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2008, 4:44-57.
8. Davidson T.S., DiPaolo R.J., Andersson J., Shevach E.M. Cutting edge: IL-2 is essential for TGF-β-mediated induction of Foxp3+ T regulatory cells. The Journal of Immunology 2007, 178:4022-4026.
9. Du C., Liu C., Kang J., Zhao G., Ye Z., Huang S., Li Z., Wu Z., Pei G. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nature Immunology 2009, 10:1252-1259.
10. Dweep H., Sticht C., Pandey P., Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. Journal of Biomedical Informatics 2011, 44:839-847.
11. + cell activation in patients with multiple sclerosis. Neuroscience Letters 2011, 504:9-12.
12. Fujishima S., Watanabe H., Kawaguchi M., Suzuki T., Matsukura S., Homma T., Howell B.G., Hizawa N., Mitsuya T., Huang S.-K. Involvement of IL-17F via the induction of IL-6 in psoriasis. Archives of Dermatological Research 2010, 302:499-505.
13. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunology 2005, 6:1123-1132.
14. Hauser S.L., Oksenberg J.R. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006, 52:61-76.
15. Hsu S.-D., Lin F.-M., Wu W.-Y., Liang C., Huang W.-C., Chan W.-L., Tsai W.-T., Chen G.-Z., Lee C.-J., Chiu C.-M. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Research 2011, 39:D163-D169.
16. Huter E.N., Punkosdy G.A., Glass D.D., Cheng L.I., Ward J.M., Shevach E.M. TGF-β-induced Foxp3+ regulatory T cells rescue scurfy mice. European Journal of Immunology 2008, 38:1814-1821.
17. Jacobs J.P., Wu H.-J., Benoist C., Mathis D. IL-17-producing T cells can augment autoantibody-induced arthritis. Proceedings of the National Academy of Sciences 2009, 106:21789-21794.
18. Kanehisa M., Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Research 2000, 28:27-30.
19. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. The Journal of Immunology 2006, 177:566-573.
20. Lassmann H., Brück W., Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends in Molecular Medicine 2001, 7:115-121.
21. Luzi E., Marini F., Sala S.C., Tognarini I., Galli G., Brandi M.L. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. Journal of Bone and Mineral Research 2008, 23:287-295.
22. Manel N., Unutmaz D., Littman D.R. The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nature Immunology 2008, 9:641-649.
23. Martin A.J., Zhou L., Miller S.D. MicroRNA-managing the TH-17 inflammatory response. Nature Immunology 2009, 10:1229-1231.
24. Murdaca G., Colombo B.M., Puppo F. The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Internal and Emergency Medicine 2011, 6:487-495.
25. Mycko M.P., Cichalewska M., Machlanska A., Cwiklinska H., Mariasiewicz M., Selmaj K.W. MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination. Proceedings of the National Academy of Sciences 2012, 109:E1248-E1257.
26. Niimoto T., Nakasa T., Ishikawa M., Okuhara A., Izumi B., Deie M., Suzuki O., Adachi N., Ochi M. MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskeletal Disorders 2010, 11:209.
27. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.-H., Wang Y., Hood L., Zhu Z., Tian Q. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunology 2005, 6:1133-1141.
28. Shevach E.M., Davidson T.S., Huter E.N., DiPaolo R.A., Andersson J. Role of TGF-β in the induction of Foxp3 expression and T regulatory cell function. Journal of Clinical Immunology 2008, 28:640-646.
29. Tzartos J.S., Friese M.A., Craner M.J., Palace J., Newcombe J., Esiri M.M., Fugger L. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. The American Journal of Pathology 2008, 172:146-155.
30. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
31. Yang L., Anderson D.E., Baecher-Allan C., Hastings W.D., Bettelli E., Oukka M., Kuchroo V.K., Hafler D.A. IL-21 and TGF-β are required for differentiation of human TH17 cells. Nature 2008, 454:350-352.
32. Yang J., Chu Y., Yang X., Gao D., Zhu L., Yang X., Wan L., Li M. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis & Rheumatism 2009, 60:1472-1483.